PICVA (Percutaneous In-Situ Coronary Venous Arterialization)

Cardiac transplantation - Percutaneous coronary revascularization - Pacemakers

Moderators: Radiodiagnosis Team, Primary Care Team, Cardiology Team

Forum rules
YOUR POST WILL REQUIRE APPROVAL - READ: Doctors Lounge Forum Rules and Regulations
• Use a precise title for your question otherwise it will NOT be approved.
• Do not post the same question more than once & maintain related posts in original thread.
• Do not use your real name or identifiable information - You can't edit/delete your post.

PICVA (Percutaneous In-Situ Coronary Venous Arterialization)

Postby Rigbee » Sat Dec 28, 2002 6:58 am

I am intested in any new developments in the availability of Percutaneous In-Situ Coronary Venous Arterialization (PICVA) in the U.S. My mother, who is facing a second, highly invasive bypass operation has been described as "a perfect candidate" for this procedure.

User avatar
Dr. Tamer Fouad
Medical Doctor
Posts: 2563
Joined: Thu Jan 02, 2003 6:19 pm
Gender: Male

Postby Dr. Tamer Fouad » Tue Nov 01, 2005 4:23 pm

Percutaneous in-situ coronary venous arterialization (PICVA) is gaining alot of attention recently. Especially after its initial success in saving the life of a patient suffering from cardiac infarction who was not candidate for CABG. However, as successful and promising as everything may seem it is way to early to decide whether it shows a survival benefit over traditional CABG.

Pros and Cons:
First of all this procedure has only been used on one human being in Germany and was done almost one year ago. However, it has been tested on pigs and has showed a survival benefit over CABG.

Secondly, the technique uses the coronary veins which are rarely diseased as opposed to other percutaneous techniques which use the saphenous vein or other arterial conduits that are the seat of plaques.

Lastly, the technique and devices used are still under development.

Candidates for PICVA:

Patients who can potentially benefit from the procedure include those who are candidates for various types of laser-based transmyocardial laser revascularization procedures; re-do CABG patients; patients with chronic total occlusions; and patients who are candidates for gene therapy.
Dr. Tamer Fouad, MD
MB, BCh, MSc Internal Medicine.
Consultant of Hematology - Oncology.

Return to “Cardiology Treatment Modalities”

Who is online

Users browsing this forum: No registered users and 2 guests

advertisement.gif (61x7 -- 0 bytes)

We subscribe to the HONcode principles of the HON Foundation. Click to verify.
We subscribe to the HONcode principles. Verify here

Privacy Statement | Terms & Conditions | Editorial Board | About us
Copyright © 2001-2016 Doctors Lounge. All rights reserved.